Clinical Trial Update: A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

View source ↗

Summary

The study evaluating retreatment with Brentuximab Vedotin in adults with cutaneous T-cell lymphoma has completed. The clinical trial update provides completion …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: Takeda | Conditions: T-Cell Lymphoma | Status: COMPLETED